Fort Belvoir, Virginia, Oct. 24, 2017 -- Collaboration between government, academia and industry is key to defending our warfighters and nation from the evolving threat of weapons of mass destruction. Share innovative ideas with more than 1,500 of the most influential scientists, program managers and leaders in the defense community at the 2017 Chemical and Biological Defense Science & Technology (CBD S&T) Conference Nov. 28-30, 2017, in Long Beach, Calif.
|
|||||||||
The event will feature the latest developments in basic and applied scientific research within the chemical and biological defense arena including:
- Novel Threat and Disruptive Chemical and Biological Discovery
- Dynamic Functional Materials
- Applied Mathematics and Innovative Computational Tools
- Flexible Design, Synthesis and Manufacturing
- Systems Biology and Engineering
- Disease Surveillance, Characterization and Point of Need Diagnostics
- Adaptive Medical Therapeutics and Technologies
- Rapid Response and Recovery Science and Technology
- Threat Activity Sensing and Reporting
Theoretical physicist, S. James Gates, Jr., Ph.D., specializing in supersymmetry, supergravity and superstring theory, and Ford Foundation Professor of Physics at Brown University, will deliver the keynote address. In addition, special sessions will offer a CBD S&T portfolio overview and a ‘how-to’ conduct business with DTRA presentation, a warfighter panel and a minority-serving institution panel.
Registration is now open. Visit www.cbdstconference.com for registration information.
###
The DTRA mission is to safeguard the U.S. and its allies from weapons of mass destruction (WMD), specifically chemical, biological, radiological, nuclear, and high-yield explosive threats, and improvised threats by providing the means to prevent and counter the proliferation of WMD and improvised threats and to reduce, eliminate, and mitigate their effects. This includes helping ensure the U.S. maintains a safe, secure, effective and credible nuclear weapons deterrent. As the DoD Combat Support Agency for the Counter WMD and improvised threats mission, DTRA develops and provides operational support for associated capabilities to warfighters worldwide.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/5ac4dd5a-7778-49f2-9c31-f4d47a30a65d
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/3d004a69-a8cc-4447-8523-f5de3f28d6d5
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/59f0c34e-0c34-463a-86f7-3a71e677d1d8
Defense Threat Reduction Agency 703-767-6050 [email protected]


Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 



